Sep 20, 2018
Global Rosacea Treatment Market 2018-2022: High Prevalence of Rosacea in Several Countries will Play a Key Factor Behind the Growth of the Market Across the Globe
Sep 14, 2018
Experts Call for Improved Identification of 'High Burden' Rosacea Patients in Everyday Practice
Aug 23, 2018
Kleresca® Releases Unique Biophotonic Rosacea Treatment
Aug 08, 2018
Restylane Lyft for Hand Rejuvenation Now Available at Maryland Dermatology Laser Skin & Vein Institute
Jul 31, 2018
BioPharmX Receives IRB Approval to Initiate Phase 2 Trial of BPX-04 for the Treatment of Rosacea
Jun 27, 2018
AcneFree & The American Acne & Rosacea Society Seek To Help A New Generation Of Acne Sufferers
Jun 01, 2018
Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look 'Beyond the visible'
May 24, 2018
BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients
Feb 16, 2018
Allergan Presents Data at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego
Jan 12, 2018
BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month
Dec 13, 2017
Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Oct 18, 2017
BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017
Oct 11, 2017
Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference
Sep 16, 2017
Galderma: 'Clear' (IGA 0) Rosacea Patients Experience a Delayed Time to Relapse
Sep 12, 2017
BioPharmX Announces Preliminary Data from Rosacea Feasibility Study
Sep 11, 2017
Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study
Jul 27, 2017
Summer AAD Panel to Discuss BPX-01 for Acne and Rosacea
Jun 12, 2017
Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%